Utilizing devTOXqP in a Combined Testing Approach for Identifying Developmental Toxicity Liability of Chemicals [Webinar, 2016 – Slides]
Why develop devTOX? Reduce prevalence of birth defects and decrease animal testing. Our approach represents a unique opportunity to screen compound safety using a human endpoint. devTOX quickPredictTM is a predictive, targeted biomarker assay. (devTOX DiscoveryTM, on the other hand, is a predictive, untargeted metabolomics assay.) Jessica Palmer presented this webinar in October 2016. If you would like to have her go over these slides with you, email email@example.com to set up an appointment.
Utilizing devTOXqPTM in a Combined Testing Approach for Identifying Developmental Toxicity Liability of Chemicals
[pardot-form id=”935″ title=”Webinar Slides – Utilizing devTOXqP in a Combined Testing Approach … (October 2016)”]